What is PTN's earnings growth forecast for 2026-2026?
(NYSEMKT: PTN) Palatin Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 190.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,904.13%.
Palatin Technologies's earnings in 2025 is -$4,806,166.
In 2026, PTN is forecast to generate $1,169,397 in earnings, with the lowest earnings forecast at -$867,683 and the highest earnings forecast at $3,361,080.
What is PTN's revenue growth forecast for 2026-2026?
(NYSEMKT: PTN) Palatin Technologies's forecast annual revenue growth rate of 750.29% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 10,033.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,472.88%.
Palatin Technologies's revenue in 2025 is $8,847,550.
In 2026, PTN is forecast to generate $128,092,240 in revenue, with the lowest revenue forecast at $124,286,762 and the highest revenue forecast at $133,164,509.
What is PTN's forecast return on assets (ROA) for 2026-2026?
(NYSEMKT: PTN) forecast ROA is 13.57%, which is lower than the forecast US Biotechnology industry average of 14.91%.
What is PTN's Earnings Per Share (EPS) forecast for 2026-2026?
(NYSEMKT: PTN) Palatin Technologies's current Earnings Per Share (EPS) is -$8.34. In 2026, PTN's EPS is forecast to hit $0.69 (min: -$0.51, max: $1.97).
What is PTN's forecast return on equity (ROE) for 2026-2026?
(NYSEMKT: PTN) forecast ROE is 295.01%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.